Sanofi announced on May 14 that it plans to invest at least 20 billion US dollars in the US by 2030, including drastically increasing R&D spending and investing billions of dollars in the US manufacturing industry. The company also plans to expand production capacity in the US, including direct investment in the Sanofi plant and partnerships with domestic manufacturers in the US.

Sanofi announced on May 14 that it plans to invest at least 20 billion US dollars in the US by 2030, including drastically increasing R&D spending and investing billions of dollars in the US manufacturing industry. The company also plans to expand production capacity in the US, including direct investment in the Sanofi plant and partnerships with domestic manufacturers in the US.